Biolchim S.p.A. – Trademark Portfolio
Entity Type: 09
Biolchim S.p.A. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 8 filings in this category. The portfolio also extends into Class 31 (Natural Agricultural Products) across 3 Nice Classification classes. Currently, 4 trademarks are registered and 1 is pending. Notable registered marks include KRISS, LOKER, FOLICIST, and FYLLOTON. The owner is based in Medicina (Bologna).
Via San Carlo 2130
Medicina (Bologna) 40059 , IT
Showing of trademarks Trademarks
Trademark Classifications
Biolchim S.p.A.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Biolchim S.p.A. have?
Biolchim S.p.A. has 8 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 pending, 1 cancelled.
What trademark classes does Biolchim S.p.A. file in?
Biolchim S.p.A. files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 31 (Natural Agricultural Products), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Biolchim S.p.A.'s most well-known trademarks?
Biolchim S.p.A.'s registered trademark portfolio includes well-known marks such as KRISS, LOKER, FOLICIST, and FYLLOTON. These are among 4 currently registered trademarks in the portfolio.
What is Biolchim S.p.A.'s trademark registration success rate?
Biolchim S.p.A. has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 1 application is pending review.